Chronic mild unpredictable stress after noradrenergic denervation: Attenuation of behavioural and biochemical effects of DSP-4 treatment

European Neuropsychopharmacology

Volumn 10, Issue 1, 1999, Pages 5-16

  Harro, Jaanus ^a,b   Häidkind, Riina ^a   Harro, Maarike ^a,b   Modiri, Ali Reza ^c   Gillberg, Per Göran ^c   Pähkla, Rein ^a   Matto, Vallo ^a   Oreland, Lars ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b UPPSALA UNIVERSITY   (Sweden)

^c PFIZER INC   (United States)

Author keywords

CCK(B) receptors; Depression; Locus coeruleus; Noradrenaline; adrenoceptors

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; BETA ADRENERGIC RECEPTOR; CHOLECYSTOKININ B RECEPTOR; DIHYDROALPRENOLOL; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DENERVATION; EXPLORATORY BEHAVIOR; FRONTAL CORTEX; LOCUS CERULEUS; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; STRESS; SWIMMING;

EID: 0344183096     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(99)00043-7     Document Type: Article

References (50)

1. Anisman H., Zacharko R.M. Depression: The predisposing influence of stress. Behav. Brain Sci. 5:1982;89-137.
2. Arango V., Underwood M.D., Gubbi A.V., Mann J.J. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 688:1995;121-133.
3. Archer T. Signalled and unsignalled avoidance impairments following noradrenaline depletion with DSP4: An hypothesis incorporating an associative and a non-associative factor. Scand. J. Psychol. 24:1983;75-87.
4. Archer T., Söderberg U., Ross S.B., Jonsson G. Role of olfactory bulbectomy and DSP4 treatment in avoidance learning in the rat. Behav. Neurosci. 98:1984;496-505.
5. Biegon A., Israeli M. Regionally selective increases in β adrenergic receptors in the brains of suicide victims. Brain Res. 442:1988;199-203.
6. D'Aquila P.S., Brain P., Willner P. Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression. Physiol. Behav. 56:1994;861-867.
7. D'Aquila P., Monleon S., Borsini F., Brain P., Willner P. Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant. Eur. J. Pharmacol. 340:1997;121-132.
8. Delini-Stula A., Mogilnicka E., Hunn C., Dooley D.J. Novelty-oriented behavior in the rat after selective damage of locus coeruleus projections by DSP-4, a new noradrenergic neurotoxin. Pharmacol. Biochem. Behav. 20:1984;613-618.
9. B receptor antagonists in mice: Antagonism by naltrindole. Br. J. Pharmacol. 111:1994;956-960.
10. 2- and β-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxin. Neuroscience. 9:1983;889-898.
11. Dooley D.J., Mogilnicka E., Delini-Stula A., Waechter F., Truog A., Wood J. Functional supersensitivity to adrenergic agonists after DSP-4, a selective noradrenergic neurotoxin. Psychopharmacology. 81:1983;1-5.
12. Felice L.J., Felice J.D., Kissinger P.T. Determination of catecholamines in rat brain parts by reversed-phase ion-pair liquid chromatography. J. Neurochem. 31:1978;1461-1465.
13. Fritschy J.-M., Grzanna R. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals. Neuroscience. 30:1989;181-197.
14. Forbes N.F., Stewart C.A., Matthews K., Reid I.C. Chronic mild stress and sucrose consumption: Validity as a model of depression. Physiol. Behav. 60:1996;1481-1484.
15. Garcia-Marquez C., Armario A. Chronic stress depresses exploratory activity and behavioural performance in the forced swimming test without altering ACTH response to a novel acute stressor. Physiol. Behav. 40:1987;33-38.
16. Hall C.S. Emotional behavior in the rat: Defecation and urination as measures of individual differences in emotionality. J. Comp. Psychol. 18:1934;385-403.
17. Harro J., Jossan S.S., Oreland L. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment. Naunyn-Schmiedeberg's Arch. Pharmacol. 346:1992;425-431.
18. Harro J., Oreland L., Vasar E., Bradwejn J. Impaired exploratory behaviour after DSP-4 treatment in rats: Implications for the increased anxiety after noradrenergic denervation. Eur. Neuropsychopharmacol. 5:1995;272-280.
19. Harro J., Oreland L. Depression as a spreading neuronal adjustment disorder. Eur. Neuropsychopharmacol. 6:1996;207-223.
20. B receptor binding in the rat brain after chronic antidepressant treatment. Naunyn-Schmiedeberg's Arch. Pharmacol. 355:1997;57-63.
21. B receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice. Eur. J. Pharmacol. 261:1994;257-263.
22. Jonsson G., Hallman H., Ponzio F., Ross S. DSP-4 [N(2-chloroethyl)-N-ethyl-2-bromobenzylamine]: A useful denervation tool for central and peripheral noradrenaline neurons. Eur. J. Pharmacol. 72:1981;173-188.
23. Jonsson G., Hallman H., Sundström E. Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat. Neuroscience. 7:1982;2895-2907.
24. Kask A., Harro J., Tuomainen P., Rägo L., Männistö P.T. Overflow of noradrenaline and dopamine in frontal cortex after [N(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: In vivo microdialysis study in anaesthetized rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 355:1997;267-272.
25. Katz R. Animal model of depression: Pharmacological sensitivity of a hedonic deficit. Pharmacol. Biochem. Behav. 16:1981;965-968.
26. Katz R.J., Roth K.A., Carroll B.J. Acute and chronic stress effects on open field activity in the rat: Implications for a model of depression. Neurosci. Biobehav. Rev. 5:1981;247-251.
27. 2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch. Gen. Psychiat. 43:1986;954-959.
28. Matthews K., Forbes N., Reid I.C. Sucrose consumption as a hedonic measure following chronic unpredictable mild stress. Physiol. Behav. 57:1995;241-248.
29. Molina V.A., Heyser C.J., Patia Spear L. Chronic variable stress enhances the stimulatory action of a low dose of morphine: Reversal by desipramine. Eur. J. Pharmacol. 260:1994;57-64.
30. Molina V.A., Heyser C.J., Patia Spear L. Chronic variable stress or chronic morphine facilitates immobility in a forced swim test: Reversal by naloxone. Psychopharmacology. 114:1994;433-440.
31. Moreau J.-L., Jenck F., Martin J.R., Mortas P., Haefely W.E. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation in rats. Eur. Neuropsychopharmacol. 2:1992;43-49.
32. Muscat R., Willner P. Suppression of sucrose drinking by chronic mild unpredictable stress. A methodological analysis. Neurosci. Biobehav. Rev. 16:1992;507-517.
33. Papp M., Klimek V., Willner P. Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression. Psychopharmacology. 114:1994;309-314.
34. Papp M., Willner P., Muscat R. An animal model of anhedonia: Attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology. 104:1991;255-259.
35. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: A new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47:1978;379-391.
36. Rinken A., Harro J., Engström L., Oreland L. Role of fluidity of membranes on the guanyl nucleotide-dependent binding of cholecystokinin-8S to rat brain cortical membranes. Biochem. Pharmacol. 55:1998;423-431.
37. 3H]dihydroalprenolol. J. Pharmacol. Exp. Ther. 36:1992;201-210.
38. Rosellini R.A. Inescapable shock interferes with the acquisition of a free appetitive operant. Anim. Learn. Behav. 6:1978;155-159.
39. Ross S.B. Long-term effect of N-2-chloroethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurons in the rat brain and heart. Br. J. Pharmacol. 58:1976;521-527.
40. Sharp T., Zetterström T. In vivo measurement of monoamine neurotransmitter release using brain microdialysis. Stamford J.A. Monitoring Neuronal Activity: A Practical Approach. 1992;147-177 Oxford University Press, Oxford.
41. Theron C.N., de Villiers A.S., Taljaard J.J.F. Effects of DSP-4 on monoamine and monoamine metabolite levels and on beta adrenoceptor binding kinetics in rat brain at different times after administration. Neurochem. Res. 18:1993;1321-1327.
42. Tsaltas E., Gray J.A., Preston G.S. Effects of lesions to the dorsal noradrenergic bundle on counterconditioning of punished barpressing. Physiol. Behav. 40:1987;7-15.
43. B receptor antagonist. Psychopharmacology. 131:1997;79-85.
44. Willner P. Dopaminergic mechanisms in depression and mania. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;921-931 Raven Press, New York.
45. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology. 134:1997;319-329.
46. Willner P., Moreau J.-L., Kurre Nielsen C., Papp M., Sluzewska A. Decreased hedonic responsiveness following chronic mild stress is not secondary to loss of body weight. Physiol. Behav. 60:1996;129-134.
47. Willner P., Muscat R., Papp M. Chronic mild stress-induced anhedonia: A realistic animal model of depression. Neurosci. Biobehav. Rev. 16:1992;525-534.
48. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology. 93:1987;358-364.
49. Wolfman C., Abo V., Calvo D., Medina J., Dajas F., Silveira R. Recovery of central noradrenergic neurons one year after the administration of the neurotoxin DSP4. Neurochem. Int. 25:1994;395-400.
50. Zacharko R.M., Bowers W.J., Kokkinidis L., Anisman H. Region specific reductions of intracranial self-stimulation after uncontrollable stress: Possible effects on reward processes. Behav. Brain Res. 9:1983;129-141.